Food and Drug Administration

March 28, 2012

Acorda Therapeutics' Ron Cohen presented testimony on the importance of federal policies...

February 22, 2012

The 14th Annual BIO CEO & Investor Conference was held on February 13-14 in New York City...

November 3, 2011

BIO President and CEO Jim Greenwood congratulated the FDA and biopharmaceutical sponsors for...

November 3, 2011

Underlying the PDUFA V recommendations are the principles that a science-based, transparent,...

Letters, Testimony & Comments

February 27 2013
    Dear Sir/Madam:    The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration...
February 19 2013
    The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the...
February 4 2013
  The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to provide...
January 22 2013
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to...
January 22 2013
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to...

Press Releases

February 9 2012
Patient Safety Must Remain Top Priority Washington, D.C. (February 9, 2012) — Biotechnology Industry...
February 1 2012
Washington, D.C. (February 1, 2012) – Richard Pops, Chairman and CEO of Alkermes plc, testified today on behalf...
October 4 2011
Washington, D.C. (October 4, 2011) – A coalition of anti-technology groups under the moniker “Just Label...
September 1 2011
Washington, D.C. (September 1, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim...
August 3 2011
Washington, D.C. (August 3, 2011) – In a letter to Congressional Leadership, the Biotechnology Industry...